Conclussion: Therapeutic regimen combined with immunosuppressive agents and anti-viral medication Tenofovir can achive remission of HBV-related nephrotic syndrome, which did not respond with anti-viral drug alone, without reactivation of viral replication and acceleration of hepatic injuries.